InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.25
(
-0.10%
)
Bitcoin
57,193.26
(
0.36%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

vidpok45

Send PM Follow Ignore
Followers 0
Posts 4859
Boards Moderated 0
Alias Born 06/15/2010

vidpok45

Re: jbog post# 79416

Wednesday, 12/07/2016 6:02:10 AM

Wednesday, December 07, 2016 6:02:10 AM

Post# of 80490
The fact that Novartis' drug is intended for first line use doesn't mean it has to be tested on criz naive patients. If that was directly from the article then it is confusing as Brigatinib is going after first line use but will have been tested on prior failure patients which is why the direct comparison between the two drugs isnt possible with Brigatinib obviously way ahead.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up